{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:03:40Z","timestamp":1779771820058,"version":"3.53.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neuropharm.2026.110996","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:59:59Z","timestamp":1777993199000},"page":"110996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PPAR-\u03b1 activation in a model of autism modulates social reward and endocannabinoid signaling selectively in male rats"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9140-9158","authenticated-orcid":false,"given":"S.","family":"Salviati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7742-9604","authenticated-orcid":false,"given":"G.","family":"Braccagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9845-885X","authenticated-orcid":false,"given":"E.","family":"Corridori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5659-4454","authenticated-orcid":false,"given":"G.","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9235-5874","authenticated-orcid":false,"given":"F.","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-7426","authenticated-orcid":false,"given":"M.","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1936-6710","authenticated-orcid":false,"given":"N.","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-6090","authenticated-orcid":false,"given":"S.","family":"Scheggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-7668","authenticated-orcid":false,"given":"C.","family":"Gambarana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110996_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorder: DSM-V. Arlington","year":"2013"},{"key":"10.1016\/j.neuropharm.2026.110996_bib2","article-title":"Beneficial effects of palmitoylethanolamide on expressive language, cognition, and behaviors in autism: a report of two cases","volume":"2015","author":"Antonucci","year":"2015","journal-title":"Case Rep. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110996_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2026.110996_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-0716-2728-0_4","article-title":"LC-MS\/MS analysis of AEA and 2-AG","volume":"2576","author":"Battista","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cns.12648","article-title":"Beneficial effects of Co-Ultramicronized palmitoylethanolamide\/Luteolin in a mouse model of autism and in a case report of autism","volume":"23","author":"Bertolino","year":"2017","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110996_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100951","article-title":"Endocannabinoid LTD in accumbal D1 neurons mediates reward-seeking behavior","volume":"23","author":"Bilbao","year":"2020","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110996_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/brainsci14070733","article-title":"Dopamine dysregulation in reward and autism spectrum disorder","volume":"14","author":"Blum","year":"2024","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40617-018-0229-9","article-title":"Task interspersal implementation practices with individuals with autism spectrum disorder","volume":"12","author":"Bottini","year":"2018","journal-title":"Behavior Anal. Pract."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110996_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2051-0","article-title":"Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice","volume":"214","author":"Cassano","year":"2011","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110996_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s13311-015-0371-9","article-title":"Endocannabinoid signaling in autism","volume":"12","author":"Chakrabarti","year":"2015","journal-title":"Neurotherapeutics: J.Am. Soc. Exper. NeuroTherapeut."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110996_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tics.2012.02.007","article-title":"The social motivation theory of autism","volume":"16","author":"Chevallier","year":"2012","journal-title":"Trends Cognit. Sci."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110996_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamapsychiatry.2018.1100","article-title":"Evaluation of the social motivation Hypothesis of autism: a systematic review and meta-analysis","volume":"75","author":"Clements","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110996_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbi.2018.09.003","article-title":"Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf\/J mice: contribution of central and peripheral mechanisms","volume":"74","author":"Cristiano","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.110996_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114256","article-title":"Endocannabinoid markers in autism spectrum disorder: a scoping review of human studies","volume":"306","author":"De Pol","year":"2021","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110996_bib14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/mp.2017.75","article-title":"Autism spectrum disorders: a meta-analysis of executive function","volume":"23","author":"Demetriou","year":"2018","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110996_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10803-011-1221-1","article-title":"Reward circuitry function in autism during face anticipation and outcomes","volume":"42","author":"Dichter","year":"2012","journal-title":"J. Autism Dev. Disord."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1866-1955-4-20","article-title":"Reward processing in autism: a thematic series","volume":"4","author":"Dichter","year":"2012","journal-title":"J. Neurodev. Disord."},{"issue":"9078","key":"10.1016\/j.neuropharm.2026.110996_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0140-6736(05)63326-0","article-title":"Low medial prefrontal dopaminergic activity in autistic children","volume":"350","author":"Ernst","year":"1997","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.neuropharm.2026.110996_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2025.114929","article-title":"The endocannabinoid and paracannabinoid systems in natural reward processes: possible pharmacological targets?","volume":"296","author":"Friuli","year":"2025","journal-title":"Physiol. Behav."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110996_bib20","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.3390\/ijms21103576","article-title":"Prenatal exposure to valproic acid affects microglia and synaptic ultrastructure in a brain-region-specific manner in young-adult Male rats: relevance to autism spectrum disorders","volume":"21","author":"G\u0105ssowska-Dobrowolska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110996_bib21","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1038\/s41380-023-02182-0","article-title":"PPAR\u03b1 and PPAR\u03b3 are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice","volume":"28","author":"Hempel","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110996_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5607\/en.2018.27.5.321","article-title":"Sex-specific behavioral features of rodent models of autism spectrum disorder","volume":"27","author":"Jeon","year":"2018","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110996_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pbb.2015.04.001","article-title":"Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress","volume":"133","author":"Jin","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110996_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.169","article-title":"Endocannabinoid signaling in social functioning: an RDoC perspective","volume":"6","author":"Karhson","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110996_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2026.110996_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","article-title":"Alterations in the endocannabinoid system in the rat valproic acid model of autism","volume":"249","author":"Kerr","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110996_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jpsychires.2018.04.022","article-title":"Palmitoylethanolamide as adjunctive therapy for autism: efficacy and safety results from a randomized controlled trial","volume":"103","author":"Khalaj","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2026.110996_bib28","article-title":"Dopaminergic dysregulation in syndromic autism spectrum disorders: insights from genetic mouse models","volume":"15","author":"Kosillo","year":"2021","journal-title":"Front. Neural Circ."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110996_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/brainsci15040388","article-title":"Sex-Specific behavioral features of the prenatal valproic acid rat model of autism spectrum disorder","volume":"15","author":"Mamali","year":"2025","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2011.01.044","article-title":"Social encounter with a novel partner in adolescent rats: activation of the central endocannabinoid system","volume":"220","author":"Marco","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110996_bib31","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.psyneuen.2013.04.004","article-title":"Emotional, endocrine and brain anandamide response to social challenge in infant male rats","volume":"38","author":"Marco","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"18","key":"10.1016\/j.neuropharm.2026.110996_bib32","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"Melancia","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1871527311312010012","article-title":"Physiological role of peroxisome proliferator-activated receptors type \u03b1 on dopamine systems","volume":"12","author":"Melis","year":"2013","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110996_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopsych.2010.04.016","article-title":"Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors","volume":"68","author":"Melis","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"14","key":"10.1016\/j.neuropharm.2026.110996_bib35","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1523\/JNEUROSCI.4647-12.2013","article-title":"PPAR\u03b1 regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving \u03b17 nicotinic acetylcholine receptors","volume":"33","author":"Melis","year":"2013","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110996_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020766","article-title":"Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats","volume":"6","author":"Murillo-Rodr\u00edguez","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/ijms24010709","article-title":"Profound modification of fatty acid profile and endocannabinoid-related mediators in PPAR\u03b1 agonist fenofibrate-treated mice","volume":"24","author":"Murru","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110996_bib38","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.3390\/ijms23094764","article-title":"Molecular alterations of the endocannabinoid system in psychiatric disorders","volume":"23","author":"Navarro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110996_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2023.08.009","article-title":"The dopamine hypothesis of autism spectrum disorder: a comprehensive analysis of the evidence","volume":"173","author":"Pav\u0103l","year":"2023","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110996_bib39","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2026.110996_bib42","article-title":"The role of dopamine and endocannabinoid systems in prefrontal cortex development: adolescence as a critical period","volume":"16","author":"Peters","year":"2022","journal-title":"Front. Neural Circ."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2026.110996_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2013.07.026","article-title":"More surprises lying ahead. The endocannabinoids keep us guessing","volume":"76","author":"Piomelli","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110996_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100317","article-title":"Brain histamine and oleoylethanolamide restore behavioral deficits induced by chronic social defeat stress in mice","volume":"14","author":"Rani","year":"2021","journal-title":"Neurobiol. Stress"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13293-024-00621-3","article-title":"Differently different?: a commentary on the emerging social cognitive neuroscience of female autism","volume":"15","author":"Rippon","year":"2024","journal-title":"Biol. Sex Differ."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110996_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei","volume":"370","author":"Rodier","year":"1996","journal-title":"J. Comp. Neurol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110996_bib46","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/s41386-020-0686-z","article-title":"Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge eating disorder","volume":"45","author":"Romano","year":"2020","journal-title":"Neuropsychopharmacology: Off. Public. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110996_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2019.02.026","article-title":"Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants","volume":"149","author":"Romero-Sanchiz","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110996_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism--a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13229-020-00358-x","article-title":"Targeting PPAR\u03b1 in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences","volume":"11","author":"Scheggi","year":"2020","journal-title":"Mol. Autism"},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2026.110996_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuropharm.2016.07.024","article-title":"PPAR\u03b1 modulation of mesolimbic dopamine transmission rescues depression-related behaviors","volume":"110","author":"Scheggi","year":"2016","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110996_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/biom12050723","article-title":"PPAR\u03b1 signaling: a candidate target in psychiatric disorder management","volume":"12","author":"Scheggi","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.110996_bib52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fncel.2019.00479","article-title":"Reward-related behavioral, neurochemical and electrophysiological changes in a rat model of autism based on prenatal exposure to valproic acid","volume":"13","author":"Schiavi","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110996_bib53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41386-022-01454-7","article-title":"Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats","volume":"48","author":"Schiavi","year":"2023","journal-title":"Neuropsychopharmacology: Off. Public. Am. Coll. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology : Off. Public. Am. Coll. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110996_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.182","article-title":"Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid","volume":"6","author":"Servadio","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110996_bib56","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1007\/s10803-022-05670-4","article-title":"Towards a Neurodiversity-Affirmative approach for an over-represented and under-recognised population: autistic adults in outpatient psychiatry","volume":"52","author":"Shaw","year":"2022","journal-title":"J. Autism Dev. Disord."},{"issue":"43","key":"10.1016\/j.neuropharm.2026.110996_bib57","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","article-title":"Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats","volume":"32","author":"Trezza","year":"2012","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110996_bib58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.euroneuro.2009.03.006","article-title":"Conditioned place preference induced by social play behavior: parametrics, extinction, reinstatement and disruption by methylphenidate","volume":"19","author":"Trezza","year":"2009","journal-title":"Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2026.110996_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110996_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.plipres.2010.02.003","article-title":"N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)","volume":"49","author":"Ueda","year":"2010","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110996_bib61","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jamapsychiatry.2018.3645","article-title":"Patterns of nonsocial and social cognitive functioning in adults with autism spectrum disorder: a systematic review and meta-analysis","volume":"76","author":"Velikonja","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110996_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep27618","article-title":"Localization of PPAR isotypes in the adult mouse and human brain","volume":"6","author":"Warden","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110996_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tins.2017.04.005","article-title":"Endocannabinoid signaling in the control of social behavior","volume":"40","author":"Wei","year":"2017","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110996_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2015.0008","article-title":"Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment","volume":"1","author":"Wei","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"issue":"45","key":"10.1016\/j.neuropharm.2026.110996_bib65","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1073\/pnas.1509795112","article-title":"Endocannabinoid signaling mediates oxytocin-driven social reward","volume":"112","author":"Wei","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110996_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13105-016-0532-2","article-title":"Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features","volume":"73","author":"Yadav","year":"2017","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2026.110996_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2023.1256764","article-title":"Quantifying conditioned place preference: a review of current analyses and a proposal for a novel approach","volume":"17","author":"Yates","year":"2023","journal-title":"Frontiers Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110996_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neulet.2015.03.019","article-title":"Involvement of norepinephrine and serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models of behavior despair","volume":"593","author":"Yu","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110996_bib69","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/ijms18091916","article-title":"The endocannabinoid system and autism spectrum disorders: insights from animal models","volume":"18","author":"Zamberletti","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:24:46Z","timestamp":1779769486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":69,"alternative-id":["S0028390826001693"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110996","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR-\u03b1 activation in a model of autism modulates social reward and endocannabinoid signaling selectively in male rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110996"}}